|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-11-2
|
|
pubmed:abstractText |
Epidermal growth factor receptor (EGFR) signaling has been implicated in the genesis and progression of cholangiocarcinoma. However, the characteristics of EGFR signaling in cholangiocarcinoma cells have not been characterized. Thus, we attempted to more fully characterize EGF/EGFR signaling in human cholangiocarcinoma cells.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases,
http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Tyrphostins,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin,
http://linkedlifedata.com/resource/pubmed/chemical/gefitinib,
http://linkedlifedata.com/resource/pubmed/chemical/tyrphostin AG 1478
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
808-14
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:15519654-Bile Duct Neoplasms,
pubmed-meshheading:15519654-Bile Ducts, Intrahepatic,
pubmed-meshheading:15519654-Cell Line, Tumor,
pubmed-meshheading:15519654-Cholangiocarcinoma,
pubmed-meshheading:15519654-Cyclooxygenase 2,
pubmed-meshheading:15519654-Enzyme Inhibitors,
pubmed-meshheading:15519654-Humans,
pubmed-meshheading:15519654-Membrane Proteins,
pubmed-meshheading:15519654-Phosphorylation,
pubmed-meshheading:15519654-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:15519654-Quinazolines,
pubmed-meshheading:15519654-Receptor, Epidermal Growth Factor,
pubmed-meshheading:15519654-Signal Transduction,
pubmed-meshheading:15519654-Tyrphostins,
pubmed-meshheading:15519654-Ubiquitin
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells.
|
|
pubmed:affiliation |
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul 110-744, South Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
